©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 110106
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.110106
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.110106
Table 5 Antifungal susceptibility testing of isolates, n (%)
| Result | Resistant | Susceptible | Total |
| Fluconazole | 12 (15.19) | 67 (84.81) | 79 |
| Voriconazole | 13 (16.46) | 66 (83.54) | 79 |
| Caspofungin | 16 (20.25) | 63 (79.75) | 79 |
| Micafungin | 26 (32.91) | 53 (67.09) | 79 |
| Amphotericin B | 11 (13.92) | 68 (86.08) | 79 |
| Flucytosine | 11 (13.92) | 68 (86.08) | 79 |
- Citation: Choudhary S, Mishra RK, Parihar S, Kinimi SV, Yadav R, Grotra R. Pediatric Candiduria: Insights from an observational study at a tertiary care hospital in northwestern India. World J Clin Pediatr 2025; 14(4): 110106
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/110106.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.110106